Skip to main content

Table 3 Ocular, nasal, asthma and overall allergic symptoms using Visual Analogue Scales (VAS) for symptoms and total symptom and medication score (TSMS) (i.e., considering medication use on the respective days)

From: Effect of nasal irrigation on allergic rhinitis control in children; complementarity between CARAT and MASK outcomes

 Active (n: 55)Control (n: 23)p-value*
Ocular symptomsa1.3 (0.1–8.5)4.1 (0.2–10.3)0.482
Nasal symptomsa20.0 (9.2–27.6)20.6 (9.0–28.7)0.936
Asthma symptomsa0.4 (0.0–9.5)0.1 (0.0–3.0)0.503
Overall allergic symptomsa18.0 (8.7–26.3)18.6 (11.6–27.8)0.701
Ocular TSMSb9.5 (6.5–17.4)15.7 (12.2–23.6)0.019
Nasal TSMSb18.8 (12.9–22.3)23.6 (17.3–28.0)0.046
Asthma TSMSb10.8 (6.6–16.8)15.6 (11.1–20.4)0.039
Overall allergic TSMSb17.6 (13.0–22.1)23.6 (14.1–28.2)0.035
  1. p-values < 0.05 are shown in italics
  2. Values shown as medians and 25–75 percentiles
  3. * Wilcoxon’s rank-sum test
  4. aMean daily VAS
  5. bMean daily TSMS